Astrana Health, Inc. Quarterly Amortization of Intangible Assets in USD from Q3 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Astrana Health, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q3 2013 to Q3 2024.
  • Astrana Health, Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $6.7M, a 109% increase year-over-year.
  • Astrana Health, Inc. Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $21.2M, a 68.3% increase year-over-year.
  • Astrana Health, Inc. annual Amortization of Intangible Assets for 2023 was $12.7M, a 7.3% decline from 2022.
  • Astrana Health, Inc. annual Amortization of Intangible Assets for 2022 was $13.7M, a 11% decline from 2021.
  • Astrana Health, Inc. annual Amortization of Intangible Assets for 2021 was $15.4M, a 3.75% decline from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $21.2M $6.7M +$3.5M +109% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $17.7M $6.9M +$3.6M +109% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $14.1M $4.4M +$1.4M +46.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $12.7M $3.2M +$100K +3.23% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $12.6M $3.2M -$200K -5.88% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $12.8M $3.3M -$200K -5.71% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $13M $3M -$700K -18.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $13.7M $3.1M -$700K -18.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $14.4M $3.4M -$700K -17.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $15.1M $3.5M -$200K -5.41% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $15.3M $3.7M -$100K -2.63% Jan 1, 2022 Mar 31, 2022 10-Q/A 2023-08-09
Q4 2021 $15.4M $3.8M +$100K +2.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $15.3M $4.1M +$100K +2.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $15.2M $3.7M -$400K -9.76% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $15.6M $3.8M -$400K -9.52% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $16M $3.7M -$500K -11.9% Oct 1, 2020 Dec 31, 2020 10-K/A 2023-08-09
Q3 2020 $16.5M $4M -$300K -6.98% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $16.8M $4.1M +$200K +5.13% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $16.6M $4.2M +$300K +7.69% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $16.3M $4.2M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $4.3M +$100K +2.38% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $3.9M -$300K -7.14% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $3.9M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-29
Q3 2018 $4.2M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $4.2M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q4 2014 $110K +$109K Oct 1, 2014 Dec 31, 2014 10-Q 2015-02-23
Q3 2014 $125K +$124K Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-14
Q4 2013 $1K* Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-23
Q3 2013 $1K* Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.